"If there can be a safe, effective and controlled mechanism for distributing pharmaceuticals online that maintains the intellectual property of U.S. companies, we wouldn't be opposed to that, " he says.
The first was managing existing intellectual property, which includes reprinting and distributing books under contract through their traditional and newer digital infrastructures through various release windows ad infinitum.